Circulation Research, Vol 69, 1042-1050, Copyright © 1991 by American Heart Association

ARTICLES

Characteristics of giant cells and factors related to the formation of giant cells in myocarditis

M Kodama, Y Matsumoto, M Fujiwara, SS Zhang, H Hanawa, E Itoh, T Tsuda, T Izumi and A Shibata
First Department of Internal Medicine, Niigata University School of Medicine, Japan.

Giant cell myocarditis is a serious and frequently fatal inflammatory heart disease of which the etiology remains unknown. In the present study, we investigated the origin of multinucleated giant cells in myocarditis with the use of an experimental model. We also examined the factors relating to the formation of giant cells in myocarditis. Severe myocarditis characterized by the appearance of multinucleated giant cells was induced in Lewis rats by immunization with cardiac myosin in complete Freund's adjuvant. Two types of giant cells, foreign body giant cell-like and myocytelike, were observed in this myocarditis. Immunohistochemical studies revealed that both types of multinucleated giant cells were stained with OX42 and ED1 (macrophage markers) and were not stained with anti-desmin antibody and HHF35 (markers for muscle fibers). Therefore, it is likely that multinucleated giant cells in this myocarditis are derived from macrophages. During the course of the disease, the appearance of multinucleated giant cells was restricted to a period corresponding with the fulminant phase of inflammation. When the severity of the disease was modulated by immunization with various doses of the antigen, multinucleated giant cells appeared only in severe myocarditis after inoculation of a large dose of the antigen. Administration of immunoadjuvants also affected the formation of giant cells. Most of the rats injected with cardiac myosin in complete Freund's adjuvant developed giant cell myocarditis.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				B. Yanagawa, M. Kataoka, S. Ohnishi, M. Kodama, K. Tanaka, Y. Miyahara, H. Ishibashi-Ueda, Y. Aizawa, K. Kangawa, and N. Nagaya Infusion of adrenomedullin improves acute myocarditis via attenuation of myocardial inflammation and edema Cardiovasc Res, October 1, 2007; 76(1): 110 - 118. [Abstract] [Full Text] [PDF]

				N. Nagaya, K. Kangawa, T. Itoh, T. Iwase, S. Murakami, Y. Miyahara, T. Fujii, M. Uematsu, H. Ohgushi, M. Yamagishi, et al. Transplantation of Mesenchymal Stem Cells Improves Cardiac Function in a Rat Model of Dilated Cardiomyopathy Circulation, August 23, 2005; 112(8): 1128 - 1135. [Abstract] [Full Text] [PDF]

				W. Liu, H. Nakamura, K. Shioji, M. Tanito, S.-i. Oka, M. K. Ahsan, A. Son, Y. Ishii, C. Kishimoto, and J. Yodoi Thioredoxin-1 Ameliorates Myosin-Induced Autoimmune Myocarditis by Suppressing Chemokine Expressions and Leukocyte Chemotaxis in Mice Circulation, September 7, 2004; 110(10): 1276 - 1283. [Abstract] [Full Text] [PDF]

				M. Afanasyeva and N.R. Rose Immune mediators in inflammatory heart disease: insights from a mouse model Eur. Heart J. Suppl., December 1, 2002; 4(suppl_I): I31 - I36. [Abstract] [PDF]

				O.-H. Kwok, E. M. C. Chau, E. P. Wang, and W.-H. Chow Coronary Artery Disease Obscuring Giant Cell Myocarditis: A Case Report Angiology, September 1, 2002; 53(5): 599 - 603. [Abstract] [PDF]

				Y. Matsumoto, Y. Jee, and M. Sugisaki Successful TCR-Based Immunotherapy for Autoimmune Myocarditis with DNA Vaccines After Rapid Identification of Pathogenic TCR J. Immunol., February 15, 2000; 164(4): 2248 - 2254. [Abstract] [Full Text] [PDF]

				S. Ishiyama, M. Hiroe, T. Nishikawa, T. Shimojo, S. Abe, H. Fujisaki, H. Ito, K. Yamakawa, N. Kobayashi, T. Kasajima, et al. The Fas/Fas Ligand System Is Involved in the Pathogenesis of Autoimmune Myocarditis in Rats J. Immunol., November 1, 1998; 161(9): 4695 - 4701. [Abstract] [Full Text] [PDF]

				S. Ishiyama, M. Hiroe, T. Nishikawa, S. Abe, T. Shimojo, H. Ito, S. Ozasa, K. Yamakawa, M. Matsuzaki, M. U. Mohammed, et al. Nitric Oxide Contributes to the Progression of Myocardial Damage in Experimental Autoimmune Myocarditis in Rats Circulation, January 21, 1997; 95(2): 489 - 496. [Abstract] [Full Text]

				S. Hirono, M. O. Islam, M. Nakazawa, Y. Yoshida, M. Kodama, A. Shibata, T. Izumi, and S. Imai Expression of Inducible Nitric Oxide Synthase in Rat Experimental Autoimmune Myocarditis With Special Reference to Changes in Cardiac Hemodynamics Circ. Res., January 1, 1997; 80(1): 11 - 20. [Abstract] [Full Text]

				E. Cabrera-Pozuelo, J. F. Val-Bernal, J. M. Torre-Hernandez, R. Gomez-Izquierdo, and J. A. Gutierrez-Sanchez Idiopathic Giant Cell Myocarditis Diagnosed in the Native Explanted Heart: Case Report and Literature Review International Journal of Surgical Pathology, January 1, 1996; 4(3): 179 - 182. [Abstract] [PDF]

				M. Kodama, S. Zhang, H. Hanawa, M. Saeki, T. Inomata, K. Suzuki, S. Koyama, and A. Shibata Effects of 15-Deoxyspergualin on Experimental Autoimmune Giant Cell Myocarditis of the Rat Circulation, February 15, 1995; 91(4): 1116 - 1122. [Abstract] [Full Text]